Dr Stephen Barclay, a GP and honorary consultant in palliative medicine, joins us to discuss the nature of palliative care today and to unpick some of the misconceptions that may be held by patients and healthcare professionals alike. How can emotion be both a doctor’s friend and foe? How can people approach the challenges faced as medical advances redefine what is possible in end of life care, though not necessarily desirable?
Is all medical practice backed by sufficient evidence? How should doctors approach uncertainty? How can we scrutinise evidence from healthcare professionals, journals or the media alike? Dr Margaret McCartney, a GP in Glasgow and strong advocate for evidence-based medicine, joins us to discuss these issues and more.
Progenitor cells in the brain can repair the damage caused by Multiple Sclerosis. Professor Robin Franklin of Cambridge's Stem Cell Institute joins us to discuss his research into remyelination of damaged neurons, how we can maintain cognitive function as we age, and the ethical considerations of researching MS.
Advances in computer science, genomics and molecular biology are redefining what we mean by personalised medicine. Dr Emma Davenport of the Wellcome Sanger Institute joins us to discuss the potential and limitations of this today and her research into more individual approaches to the treatment of sepsis.
Harvard geneticist David Sinclair joins us to talk about how we age, why we age, and how this process isn't inevitable. We discuss the key players in slowing ageing, and how the extension of all of our lifespans will change the future in dramatic ways...
From more precise control over the brain to diverse uses of anaesthetic drugs, research scientist and practicing anaesthetist Emery Brown discusses the field of anaesthesia today and where it may find itself in the future.